During liver transplantation procedures, ischemia and reperfusion processes induce cellular injury and deterioration of mitochondrial function that contributes to hepatic damage. This study aimed to investigate the liver biopsies of patients undergoing liver transplantation, the changes in the parameters of cellular bioenergetics that occur during the ischemia/reperfusion times. We also aimed to identify any relationships between variations in these parameters and clinical biomarkers of postoperative hepatocellular function and clinical outcomes.

INTRODUCTION
============

Liver transplantation is a recognized treatment for patients with end-stage liver diseases and malignant tumors of hepatic origin. The major limitation of this procedure is related to the shortage of available organs. This problem has led to the extension of the criteria for donor organs (e.g., increased donor age, prolonged cold ischemia, donation after cardiac death, and hepatic steatosis) \[[@b1-cmh-2018-0087],[@b2-cmh-2018-0087]\]. This shortage has encouraged the use of organs with poor quality that can compromise clinical outcomes \[[@b3-cmh-2018-0087]\]. Several animal studies have been conducted in an attempt to understand the molecular and cellular mechanisms involved in transplantation. One of the major mechanisms involved is ischemia/reperfusion (I/R), in which cellular damage is initiated during hypoxia. This multifactorial process occurs during liver surgery, principally during transplantation, in which there is are periods of cold and warm ischemia followed by a reperfusion period.

Ischemia and reperfusion induce cellular injury, and the deterioration of mitochondrial function and the consequent alteration in energy metabolism represent major cellular events that contribute to hepatic damage.

In animal models, studies have shown that metabolite reduction and hypoxic conditions promote reduction in the function of the mitochondrial respiratory chain and of adenosine triphosphate (ATP) synthesis. The generation of reactive oxygen species increases and promotes the peroxidation of the components of phospholipids in the inner mitochondrial membrane, creating a self-feeding negative cycle of mitochondrial dysfunction and injury. Uncoupling of oxidative phosphorylation reduces the production of energy with consequent cell death by necrosis, and the release of cytochrome c, thereby initiating apoptosis by the activation of a caspase-dependent pathway \[[@b4-cmh-2018-0087]\].

Previous research published by our team, found a relationship between mitochondrial function, duration of hepatic pedicle clamping and clinical outcome after hepatectomy \[[@b5-cmh-2018-0087]\].

To the best of our knowledge, this is the first study to evaluate the role of bioenergetics and mitochondrial dysfunction in fresh liver in the context of liver transplantation.

We aimed to investigate changes in the parameters of cellular bioenergetics that occurred during I/R in liver biopsies from patients undergoing liver transplantation and to correlate these variations with biomarkers of postoperative hepatocellular function and with clinical outcomes.

PATIENTS AND METHODS
====================

Patients undergoing liver transplantation between March 2015 and October 2016 were included. Exclusion criteria were as follows: refusal to participate and patients with human immunodeficiency virus, hepatitis C virus, or hepatitis B virus. The institutional ethics committee of the Faculty of Medicine of the University of Coimbra approved the study (registry CE-013/2014), and informed consent was obtained from each patient.

Study population and surgical procedures
----------------------------------------

The study population consisted of 28 patients, 22 males and 6 females, with a median age of 56 years (range 1--73) and a median model for end-stage liver disease score of 18 (range 10--38).

The principal indications were: hepatocellular carcinoma in cirrhotic liver in 11 cases (39.3%); cholestatic disease in six cases (21.4%); alcoholic liver cirrhosis in four cases (14.3%); familial amyloid polyneuropathy in four cases (14.3%); intoxication in two cases (*Amanita phalloides* and paracetamol) (7.1%) and a highly selected patient with metastatic colorectal cancer (3.6%).

The orthotopic liver transplantation was performed in adult patients using the piggyback technique (93%) and in pediatric patients with a reduced-size liver technique (7%).

The median total time for liver transplantation was 9 h 10 min±1 h 38 min (range 6 h--13 h 10 min). The median time of cold ischemia was 5 h 31 min±1 h 10 min (range 2 h--8 h 13 min) and warm ischemia time was 1 h 54 min±24 min (range 1 h 18 min--3 h 10 min).

The early morbidity (≤30 days) were 21% (2 infected with cytomegalovirus, 1 splenic artery aneurysm, 2 biliary leaks, and 1 primary non-function). The late morbidity (\>30 days) were 7% related to chronic liver rejection. The mortality of 7% and it was related with intestinal ischemia and a rupture of the splenic artery aneurysm. The data are shown in [Table 1](#t1-cmh-2018-0087){ref-type="table"}.

The brain-dead organ donors were 11 males and 17 females, with a median age of 54 years (range 22--82). The principal causes of death were: cerebrovascular disease (79%) with a predominance of hemorrhagic stroke (90%), traumatic brain injury (14%), and other conditions (7%).

Most of the donors were in the intensive unit care for more than 3 days (89%), and 96% required mechanical ventilation support. It should be noted that 61% of the donors had significant medical histories: arterial hypertension (50%), diabetes (10.7%), and dyslipidemia (7.1%). The donor data are detailed in [Table 2](#t2-cmh-2018-0087){ref-type="table"}.

Collection of liver biopsies
----------------------------

We consider that the period of cold ischemia begins when a donor graft is harvested using a cold perfusion solution which ends after the tissue reaches the physiological temperature during the implantation procedures. The cold ischemia process has followed by a period of warm ischemia (blood-flow without oxygen), which ends with the completion of surgical arterial anastomosis after blood-flow restoration (reperfusion).

The protocol consisted of taking 1×1 cm wedge biopsies of the liver at two time points: biopsy A, was collected at the end of the cold ischemia, and biopsy B was collected 1 h after the end of the last vascular anastomosis ([Fig. 1](#f1-cmh-2018-0087){ref-type="fig"}). Samples were divided into two slices. One fragment was placed in a preservation solution at 4°C (sucrose 250 mM, ethylene glycol tetraacetic acid \[EGTA\] 0.5 mM, hydroxyethyl-piperazineethane-sulfonic acid buffer \[HEPES\] 10 mM, pH 7.4, bovine serum albumin \[BSA\] 1%) and was directly transported to the laboratory for mitochondrial fraction isolation and measurement of membrane potential and respiratory chain function. The remainder of the sample was frozen at -80°C for assessment of ATP content.

Materials
---------

Except when noted, all compounds were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All reagents and chemicals used were of the highest grade of purity commercially available.

Mitochondrial isolation
-----------------------

The mitochondria were isolated in a homogenization medium containing 250 mM sucrose, 10 mM HEPES (pH 7.4), 0.5 mM EGTA and 0.1% fat-free BSA \[[@b6-cmh-2018-0087],[@b7-cmh-2018-0087]\]. After homogenization of the minced blood-free hepatic tissue, the homogenates were centrifuged at 800 g for 10 min at 4°C. The supernatants were spun at 10,000 g for 10 min at 4°C to pellet the mitochondria that were then re-suspended in a final washing medium. EGTA and BSA were omitted from the final washing medium, adjusted to pH 7.4. The protein content was determined by the biuret method calibrated with BSA.

Measurement of mitochondrial membrane potential
-----------------------------------------------

The mitochondrial membrane potential was estimated using an ion-selective electrode to measure the distribution of tetraphenylphosphonium (TPP^+^). The voltage response of the TPP^+^ electrode to log was linear with a slope of 59±1, in conformity with the Nernst equation. Reactions were carried out at 25°C, in a temperature-controlled water-jacketed chamber with magnetic stirring. Mitochondria (1 mg) were suspended in 1 mL of standard respiratory medium (130 mM sucrose, 50 mM potassium chloride, 5 mM magnesium chloride, 5 mM monopotassium phosphate, 50 mM EDTA, 5 mM HEPES \[pH 7.4\] and 2 μM rotenone supplemented with 3 μL TPP^+^). A matrix volume of 1.1 μL/mg protein was assumed. The measured parameters were membrane potential (mV), depolarization (mV), lag phase (seconds), and repolarization (mV). Readings were recorded in triplicate. Values for biopsy A and biopsy B were obtained, and the difference was calculated as the value in sample B minus the value in sample A.

Measurement of oxygen consumption
---------------------------------

The oxygen consumption of isolated mitochondria was determined using a Clark type polarographic oxygen electrode (Oxygraph, Hansatech Instruments Ltd., Norfolk, UK) \[[@b8-cmh-2018-0087]\]. Mitochondria (1 mg) were suspended under constant stirring, at 25°C, in 1.4 mL of standard respiratory medium, as previously defined. Mitochondria were energized with succinate (5 mM), and state 3 respiration was induced by adding 200 nmol of adenosine diphosphate (ADP). Oxygen consumption was also measured in the presence of 1 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone. State 3 and the Respiratory Control Ratio (RCR) were calculated according to Chance and Williams \[[@b9-cmh-2018-0087]\].

Initial and final values of RCR were obtained, and the difference was calculated as the value in sample B minus the value in sample A.

Measurement of ATP content
--------------------------

Liver ATP was extracted using an alkaline extraction procedure \[[@b10-cmh-2018-0087]\]. Tissue ATP levels were measured with the luciferase/luciferin assay (Sigma Chemical Co., St. Louis, MO, USA) with a PerkinElmer VICTOR 3 plate-reader fluorometer (PerkinElmer, Waltham, MA, USA), according to the manufacturer's instructions. Initial and final values of ATP were obtained, and the difference was calculated as the value in sample B minus the value in sample A.

Postoperative clinical biomarkers of liver function and clinical outcome
------------------------------------------------------------------------

Standard biochemical determinations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), total bilirubin, International Normalized Ratio (INR) were performed on postoperative days 1, 3, 5, and 7 \[[@b11-cmh-2018-0087]-[@b13-cmh-2018-0087]\]. Arterial lactate was measured every 6 h in the first 24 h. Arterial lactate clearance was calculated according to Nguyen et al. \[[@b14-cmh-2018-0087]\]

Postoperative morbidity was defined and classified according to Dindo et al. \[[@b15-cmh-2018-0087]\] Liver-specific morbidity was defined as any complication directly related to the liver procedure, namely primary nonfunction, bleeding, bile leakage, biloma, or intra-abdominal abscess \[[@b16-cmh-2018-0087],[@b17-cmh-2018-0087]\]. The overall mortality has defined as any death, occurring within 30 days after surgery \[[@b18-cmh-2018-0087]\].

Statistical analysis
--------------------

All continuous variables were presented as mean standard error of the mean unless otherwise specified. Normality of distribution was confirmed using the Kolmogorov--Smirnov and Shapiro--Wilk tests when indicated.

Continuous variables with normal distribution were determined with the Student's *t*-test and variables with non-normal distribution were compared with the Mann--Whitney *U*-test. Continuous variables were determined with Pearson correlation. Statistical analysis was performed using SPSS^TM^ (IBM SPSS Statistics for Windows, version 22.0, Released 2013, IBM Corp., Armonk, NY, USA). Significance was considered when *P*\<0.050.

RESULTS
=======

Mitochondrial membrane potential
--------------------------------

The mitochondrial membrane potential evaluates the phosphorylative capacity of isolated liver mitochondria. In this study, when the biopsies were tested using succinate, we found a statistically significant difference in the mitochondrial function parameters between biopsies A and B. Phosphorylation was induced by the addition of 100 nmol of ADP ([Fig. 2](#f2-cmh-2018-0087){ref-type="fig"}).

The data show a statistically significant reduction in all the parameters measured in the mitochondria isolated from biopsy B compared with biopsy A. The lag phase increased significantly after I/R. The following table summarizes the results obtained ([Table 3](#t3-cmh-2018-0087){ref-type="table"}).

Mitochondrial respiration
-------------------------

Mitochondrial respiration was quantified by evaluating oxygen consumption after energy inducement with succinate. The results confirmed a change in state 3 and 4 (natoms O/min/mg protein) between the two biopsies. We represent the respiratory state 3 which is related to the consumption of oxygen, and it's one of the best parameters to identify the failure of the oxidative phosphorylation which is the terminal process of cellular respiration in eukaryotes ([Fig. 3](#f3-cmh-2018-0087){ref-type="fig"}).

ATP content
-----------

The ATP content (nmol/mg protein) in biopsies were: A (9.3±0.7) and B (5.7±0.7). The following graph shows the ATP quantification present in the hepatic biopsies A and B ([Fig. 4](#f4-cmh-2018-0087){ref-type="fig"}). This represents a high influence of the I/R in the ATP yield.

I/R times and mitochondrial function
------------------------------------

The differences in the times of cold and warm ischemia and the length of the reperfusion period were evaluated. We found that the cold ischemia time was much longer (5 h 31 min±1 h 10 min) than the warm ischemia time (1 h 54 min±24 min). No statistically significant differences were observed in the correlation of the variation of the baseline mitochondrial function and bioenergetics between biopsies A and B with respect to I/R times.

Postoperative biomarkers of liver function and clinical outcome
---------------------------------------------------------------

Mitochondrial bioenergetic activity significantly correlated with several postoperative clinical biomarkers of hepatocellular necrosis (AST and ALT on days 1, 3, and 5) and liver function (arterial lactate 0 h, INR on day 3).

The most significant correlations were observed in lag phase variation and AST value on day 1 (r=0.596, *P*=0.007) and AST on day 3 (r=0.630, *P*=0.004) ([Fig. 5](#f5-cmh-2018-0087){ref-type="fig"}); and in the variation of RCR with arterial lactate at 0 h (r=-0,587, *P*=0.008) ([Table 4](#t4-cmh-2018-0087){ref-type="table"}).

According to the Dindo-Clavien classification, major morbidities defined as grade III--V occurred in 6 (21%) patients. Liver complications occurred in three (14.3%) patients: bile leakage in two cases (7%; grade IIIB) and primary nonfunction in one case (3.6%; grade IVA).

We found a correlation between the variation in respiratory state 3 and late morbidity (\>30 days) (r=-0.533, *P*=0.019). No significant differences were observed in the correlation of the remaining mitochondrial function parameters with early morbidity (\<30 days), late morbidity (\>30 days), or mortality ([Table 5](#t5-cmh-2018-0087){ref-type="table"}).

DISCUSSION
==========

The liver is a complex organ in which several synthesis and secretion functions are processed. The most abundant type of liver cells are hepatocytes; however, there are also other cellular elements, including epithelial cells of the bile ducts, hepatic sinusoidal endothelial cells, and Kupffer cells.

To maintain its processes of synthesis as well as elimination of toxic substances, the liver requires high levels of oxygen, making it extremely susceptible to I/R injury.

I/R injury is an inherent phenomenon of liver surgery, in which all of liver parenchymal cells are subjected to rapid and prolonged contact with the external environment. This process can lead to changes in cellular structure and can interfere with the function of intracellular organelles. The mitochondria are among the organelles most susceptible to I/R injury, with interference in energy production; they are also involved in autophagy and cellular apoptosis \[[@b19-cmh-2018-0087]\].

I/R related injuries are specific to liver transplantation because in these procedures, warm ischemia is preceded by a period of cold ischemia, in which the organ is kept in a preservation solution at 4°C for varying lengths of time \[[@b20-cmh-2018-0087]\].

Many studies in *in vivo* or *ex vivo* models have assessed the impact of the I/R process on hepatic mitochondrial function \[[@b21-cmh-2018-0087]\].

To the best of the authors' knowledge, this study is the first to determine these effects in fresh liver tissue in the context of human liver transplantation. We evaluated changes between two liver samples designated as A (collected at the end of cold ischemia) and B (collected 1 h after the last vascular anastomosis, corresponding to the hepatic artery anastomosis). To evaluate the bioenergetic mitochondrial parameters it is mandatory to use fresh tissue; therefore, the samples were immediately processed in the laboratory.

We identified statistically significant differences between the two samples with respect to mitochondrial membrane potential, mitochondrial respiration, and ATP content. These results confirmed the intimate relationship between hepatic mitochondrial function and the I/R process.

Several studies, mostly performed in animal models, showed differences in the cellular and molecular mechanisms between periods of cold and warm ischemia \[[@b22-cmh-2018-0087]\]. According to these studies, hepatocytes were most affected during warm ischemia, while hepatic sinusoidal endothelial cells were more susceptible to cold ischemia \[[@b23-cmh-2018-0087]\].

In this study, we evaluated whether these differences in mitochondrial function and bioenergetic activity were related to the variations in the lengths in the periods of cold and warm ischemia. No statistical correlation was observed for the variations in the cold and warm ischemia times or for the entire period of the surgical intervention.

In liver transplantation, there is a high variability in the length of the periods of cold ischemia, including organ removal, transport, and maintenance in preservation solution at 4ºC, until the conditions are ideal to start the anastomosis of the graft. In this study, the period of cold ischemia varied from 2 to 8 h, with 12 h currently considered to be the maximum acceptable interval for liver transplantation. In turn, the amount of time for warm ischemia was shorter and less variable (mean 2 h). The small variations in cold ischemia times and the short periods of reperfusion until samples were collected may explain the absence of statistical significance related to the I/R time \[[@b24-cmh-2018-0087]\].

Clinical results have established a statistically significant relationship between mitochondrial bioenergetics and postoperative clinical markers of cell necrosis. There was a moderate correlation between lag phase variation and AST values on postoperative days 1 and 3. This correlation reflects an increase in hepatocellular necrosis triggered by the bioenergetic deficit related to the inefficiency of the oxidative phosphorylation process \[[@b25-cmh-2018-0087],[@b26-cmh-2018-0087]\].

A moderate correlation between changes in RCR and arterial lactate values at the end of the surgical intervention and clearance of arterial lactate was identified. It should be noted that arterial lactate is a significant marker of liver function. Arterial lactate is reconverted into glucose by the Cori cycle in the liver. An incremental increase in arterial lactate reflects the failure of the Cori cycle, another signal of mitochondrial dysfunction \[[@b27-cmh-2018-0087]-[@b29-cmh-2018-0087]\]. In recent reports, arterial lactate was a predictor of graft dysfunction in liver transplantation, although further studies are needed to determine the best time point for lactate measurement \[[@b30-cmh-2018-0087],[@b31-cmh-2018-0087]\].

In our evaluation of the relationship between mitochondrial bioenergy data, despite the low rate of liver-related complications, we identified a correlation between respiratory state 3 variation and late complications. In the remaining results, there were no correlations between mitochondrial bioenergy variables and morbidity, mortality, or the number of days of hospitalization.

In this clinical study, we performed a wedge biopsy in the early reperfusion but if it were possible, it would be interesting to perform a wedge biopsy several hours after reperfusion. Another limitation of this study was related to the low rate of morbidity and mortality.

We confirmed the similarity of the mechanisms involved in I/R injury described in animal models and provided contributions to the development of new pharmacological strategies to mitigate the effects of I/R on mitochondrial activity.

The correlation of some markers of hepatic function and hepatocellular necrosis with bioenergetic mitochondrial parameters can be used as prognostic factors of the mitochondrial activity in liver transplantation. The future use of these clinical markers may allow the early identification of post-transplant liver morbidity or mortality. This may contribute to anticipating therapeutic procedures that could diminish the risk of complications, in particular, those related to post-transplant liver failure or the need to perform a new transplant.
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![Timeline of cold and warm ischemia, reperfusion, and biopsy collection. (A) Biopsy collected when the liver was removed from the donor and placed in a preservation solution at 4ºC prior to implantation. (B) Biopsy performed 1 h after the end of the last vascular anastomosis.](cmh-2018-0087f1){#f1-cmh-2018-0087}

![. Graphical representation of mitochondrial functional parameters. Mitochondrial functional parameters measured in the tetraphenylphosphonium (TPP^+^) electrode. Analysis of human liver biopsies obtained at the end of the cold ischemia period (A) and after reperfusion (B) measured with TPP^+^ electrode. Initial potential (1); Depolarization (2); Lag phase (3); and Repolarization (4). ADP, adenosine diphosphate.](cmh-2018-0087f2){#f2-cmh-2018-0087}

![Graphical representation of state 3 mitochondrial respiration in biopsies (A) and (B). A *P*-value of \<0.050 was considered statistically significant; ^\*^*P*\<0.001.](cmh-2018-0087f3){#f3-cmh-2018-0087}

![Graphical representation of the adenosine triphosphate (ATP) quantification of biopsies (A) and (B). A *P*-value of \<0.050 was considered statistically significant; ^\*^*P*\<0.001.](cmh-2018-0087f4){#f4-cmh-2018-0087}

![Correlation between postoperative aspartate aminotransferase (AST) in the 3rd postoperative day and increase in mitochondrial lag phase. Pearson correlation r=0.630, *P*=0.004. A *P*-value of \<0.050 was considered statistically significant. Represent the linearly dependent between AST and mitochondrial lag phase (circles) in the third postoperative day](cmh-2018-0087f5){#f5-cmh-2018-0087}

###### 

Patient characteristics (n=28)

  Characteristics                                      Values                                       \%
  ---------------------------------------------------- -------------------------------------------- -------
  Male/Female                                          22/6                                         79/21
  Age (years) (median, range)                          56 (1--73)                                   
  Indications                                                                                       
   Hepatocellular carcinoma in cirrhotic liver         11                                           39.3
   Primary biliary cholangitis                         4                                            14.3
   Biliary atresia                                     2                                            7.1
   Alcoholic liver cirrhosis                           4                                            14.3
   Familial amyloid polyneuropathy                     4                                            14.3
   Intoxication                                        2                                            7.1
   Metastatic colorectal cancer                        1                                            3.6
  Model for end-stage liver disease (median, range)    18 (10--38)                                  
  Total time of surgery (median±interquartile range)   9 h 10 min±1 h 38 min (6 h--13 h 10 min)     
  Time of cool ischemia (median±interquartile range)   5 h 31 min±1 h 10 min (2 h--8 h 13 min)      
  Time of warm ischemia (median±interquartile range)   1 h 54 min±24 min (1 h 18 min--3 h 10 min)   
  Intra-operative transfusion                                                                       
   Yes                                                 18                                           64
   No                                                  10                                           36
  Morbidity (≤30 days)                                                                              
   Yes                                                 6                                            21
   No                                                  22                                           79
  Morbidity (\>30 days)                                                                             
   Yes                                                 2                                            7
   No                                                  26                                           93
  Mortality                                                                                         
   Yes                                                 2                                            7
   No                                                  26                                           93

###### 

Liver graft donor characteristics (n=28)

  Donor and graft characteristics                     Values        \%
  --------------------------------------------------- ------------- ------
  Male/Female                                         11/17         
  Age (years) (median, range)                         54 (22--82)   
  Blood type                                                        
   Group A+                                           13            46
   Group A-                                           3             11
   Group O+                                           9             32
   Group O-                                           3             11
  Causes of death                                                   
   Cerebrovascular disease                            22            79
   Traumatic brain injury                             4             14
   Others                                             2             7
  Arterial hypertension                                             
   Yes                                                14            50
   No                                                 14            50
  Diabetes                                                          
   Yes                                                3             10.7
   No                                                 25            89.3
  Dyslipidemia                                                      
   Yes                                                2             7.1
   No                                                 26            92.9
  Intensive unit care                                               
   Yes                                                25            89
   No                                                 3             11
  Intensive unit care length (days) (median, range)   3 (1--9)      \-
  Mechanical ventilation support                                    
   Yes                                                25            89
   No                                                 3             11
  Steatosis grade                                                   
   0 (\<5%)                                           27            96.4
   1 (5--33%)                                         1             3.6
  Lobular inflammation                                              
   Mild                                               22            78.6
   Moderate                                           6             21.4

###### 

Mitochondrial function parameters after energy inducement with succinate in biopsies A and B

                            Biopsy A    Biopsy B    *P*-value
  ------------------------- ----------- ----------- -----------
  Initial potential (-mV)   184.8±3.1   165.9±2.9   \<0.001
  Depolarization (-mV)      22.9±0.8    15.8±0.5    \<0.001
  Lag phase (s)             76.2±2.0    127.9±1.3   \<0.001
  Repolarization (-mV)      181.2±1.4   161.9±1.2   \<0.001

Values are presented as mean±standard deviation unless otherwise indicated. A *P*-value of \<0.050 was considered statistically significant.

###### 

Mitochondrial function and post-operative hepatic function

                        Arterial lactate 0 h   AST 1st    AST 3rd    INR 3rd       AST 5th
  --------------------- ---------------------- ---------- ---------- ------------- --------------
  Variation potential   r=0.057                r=-0.095   r=-0.260   r=-0.264      r=-0.541^\*^
  Variation lag phase   r=0.100                r=0.596†   r=0.630†   r=0.519^\*^   r=0.477^\*^
  Variation state 3     r=-0.254               r=-0.065   r=-0.202   r=-0.200      r=-0.011
  Variation RCR         r=-0.587^†^            r=-0.390   r=-0.393   r=-0.227      r=-0.199
  Variation ATP         r=0.265                r=-0.259   r=-0.188   r=-0.048      r=-0.059

AST, aspartate aminotransferase; INR, International Normalized Ratio; RCR, Respiratory Control Ratio; ATP, adenosine triphosphate.

Statistically significant correlations were considered for values: ^\*^*P*\<0.050, ^†^*P*\<0.010.

###### 

Correlations between mitochondrial respiration variations between early (≤30 days) and late (\>30 days) morbidity and mortality

                    Δ State 3                                                  Δ State 4   Δ RCR
  ----------------- ---------------------------------------------------------- ----------- ----------
  Early morbidity   r=-0.377                                                   r=-0.012    r=-0.024
  Late morbidity    r=-0.533^[\*](#tfn1-cmh-2018-0087){ref-type="table-fn"}^   r=-0.063    r=-0.048
  Mortality         r=-0.094                                                   r=-0.173    r=0.334

RCR, Respiratory Control Ratio.

Statistically significant correlations were considered for values *P*\<0.050.
